News & Updates
Filter by Specialty:
Is topical better than standard steroid after cataract surgery?
Soft topical steroid application and standard steroid treatment demonstrate similar efficacy and safety in patients who underwent cataract surgery, reports a study.
Is topical better than standard steroid after cataract surgery?
07 May 2024
NCHT improves PFS in locally advanced prostate cancer
Neoadjuvant chemohormonal therapy (NCHT) plus radical prostatectomy (RP) confers significant biochemical progression-free survival (bPFS) benefits relative to neoadjuvant hormonal therapy (NHT) plus RP on patients with high-risk, locally advanced prostate cancer, reports a study.
NCHT improves PFS in locally advanced prostate cancer
06 May 2024
MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer
Patient-reported outcomes (PROs) from the phase III MIRASOL trial underpin the potential of the antibody drug conjugate mirvetuximab soravtansine (MIRV) to improve health-related quality of life (HRQoL) in women with folate receptor-alpha positive platinum-resistant ovarian cancer (FRα-positive PROC) as opposed to investigator’s choice of chemotherapy.
MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer
06 May 2024
GLP-1 RA plus SGLT-2i better than monotherapy for CV, renal events prevention
Patients with type 2 diabetes (T2D) who received combined treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have a much lower risk of major adverse cardiovascular events (MACE) and serious renal events than those treated with either drug class alone, suggests a recent study.